Related Experiment Video

Updated: Aug 21, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

Research and development of new vaccines against infectious diseases

Marie Paule Kieny1, Jean-Louis Excler, Marc Girard

  • 1Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, CH1211-Genève 27, Switzerland. kienym@who.int

American Journal of Public Health
|October 30, 2004
PubMed

Insights

Vaccine access for all children can significantly reduce infectious disease deaths. Developing new vaccines and ensuring equitable distribution are crucial for global child health.

Area of Science:

  • Global Health
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Infectious diseases cause a quarter of global deaths, disproportionately affecting children under five.
  • Current vaccination strategies are insufficient to reach all populations, particularly in resource-limited settings.

Purpose of the Study:

  • To highlight the critical need for universal access to existing basic vaccines for children.
  • To advocate for the development of novel vaccines against prevalent infectious agents.
  • To emphasize the necessity of global collaboration for vaccine accessibility.

Main Methods:

  • This study is a review and synthesis of current global health challenges related to infectious diseases and vaccination.
  • It analyzes the impact of vaccine accessibility on child mortality rates.
  • It discusses the potential of new vaccine technologies and public-private partnerships.

Main Results:

  • Equitable vaccine distribution can substantially decrease child mortality from infectious diseases.
  • Development of new vaccines is essential for infections lacking preventive measures.
  • Collaborative efforts are vital for rapid vaccine deployment.

Conclusions:

  • Achieving universal vaccine access for children is paramount to reducing global mortality.
  • Continued innovation in vaccine development and equitable distribution strategies are urgently required.
  • Public, private, and philanthropic sectors must unite to accelerate vaccine availability for vulnerable populations.

More Related Videos

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.